AzTrials
AzTrials

Disorder of Blood GasNCT04201860

Blood Gas and Bleeding Disorders in Healthy Volunteers Exposed to Nitroglycerin and Nitrogen Compounds

An observational study of Disorder of Blood Gas and Bleeding Disorder, run by Emiliano Petrucci at 1 site in Italy.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aim of the study was to investigate the possible relationship about blood gas and bleeding disorders in healthy volunteers of blasters and no blasters groups of the Italian National Mountain and Cave Rescue who handled nitrogen compounds and nitroglycerine and then they were exposed to combustion products from an… Read more about this study

Who is it for?
Ages 18 to 65 yearsHealthy volunteers can take part
Conditions the study is for
Disorder of Blood Gas, Bleeding Disorder
What is being tested?
Arterial blood gas analyses and haemostasis measures
How many people
94 participants
Where
1 siteItaly
Study dates
12 Dec 2016to 12 Dec 2019
How long will I take part?
1 Day
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: Healthy volunteers of Blasters and No Blasters Group of the Italian National Mountain and Cave Rescue

Who may be able to join

  • Healthy volunteers of Italian National Mountain and Cave Rescue

Who cannot join

  • gas exchange disorders
  • quantitative abnormalities of coagulation assessment
  • qualitative abnormalities of coagulation assessment

Trial locations and contacts

1 site in 1 country.

Italy1 site
  • Barbara Pizzi

    Avezzano, 67051

Other trials in Italy

About this study

Official title: Blood Gas and Bleeding Disorders in Healthy Volunteers Exposed to Nitroglycerin and Nitrogen Compounds of Blasting Gelatin: a Field Report During a Cave Accident

The aim of the study was to investigate the possible relationship about blood gas and bleeding disorders in healthy volunteers of blasters and no blasters groups of the Italian National Mountain and Cave Rescue who handled nitrogen compounds and nitroglycerine and then they were exposed to combustion products from an accidental uncontrolled detonation of micro-charges during a cave unblocking procedure.

Read the detailed description

This was a field report of clinical data collected during an accidental uncontrolled detonation of micro-charges, while the cave unblocking procedure was performed by volunteers of blaster group and non blasters group of the Italian National Mountain and Cave Rescue, in a cave in Trieste (Italy; altitude entrance: 348 meters above sea level; total length: 413,5 meters; total depth of 307 meters).

Before going into the cave (Time 0), the following clinical data were collected: age, sex, body mass index; smoke (yes/no), heart rate, arterial blood pressure (mean arterial pressure), oxygen saturation measured with pulse oxymetry, epitympanic temperature, blood gases analyses and the haemostasis measures.

After the accidental uncontrolled detonation of micro-charges, (Time 1) heart rate, arterial blood pressure, oxygen saturation measured with pulse oxymetry, epitympanic temperature, blood gases analyses and the haemostasis measures were recorded in each volunteers.

Being tested
Arterial blood gas analyses and haemostasis measures
Keywords
Arterial blood gas, Coagulation, Nitrogen compounds
Medical subject headings
Hemostatic Disorders, Thrombosis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Arterial blood gas analyses and haemostasis measuresDiagnostic test

    Under aseptic conditions, a puncture of radial artery was performed: three mL of the arterial blood sample were used for the haemostasis measure, while one mL was tested for the blood gases analysis.

Study groups in NCT04201860
Study groupRoleWhat they receive
Blasters groupThe volunteers of the blasters group of Italian Mountain and Cave Rescue handled explosive with nitrogen compounds and nitroglycerin of micro-charges, before the accidental uncontrolled detonation.
Receives: Diagnostic Test: Arterial blood gas analyses and haemostasis measures
Not blasters groupThe volunteers of the blasters group of Italian Mountain and Cave Rescue did not handle explosive with nitrogen compounds and nitroglycerin of micro-charges, before the accidental uncontrolled detonation.
Receives: Diagnostic Test: Arterial blood gas analyses and haemostasis measures

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change from baseline arterial blood gases analysis at 2 hours

    Under aseptic conditions, a puncture of radial artery was performed: one mL was tested for the blood gases analysis, by using i-STAT analyser.

    Measured: 10 minutes before going in to the cave and two hours after the volunteers come out from the cave

  2. Change from baseline haemostasis analysis at 2 hours

    Under aseptic conditions, a venipuncture was performed: three mL of blood sample were used for the haemostasis measure, by using Rotational Thromboelastometry

    Measured: 10 minutes before going in to the cave and two hours after the volunteers come out from the cave

Secondary outcomes (4)
  1. Change from Baseline heart rate at 2 hours

    Haert rate was recorded by using a multiparametric monitor

    Measured: 10 minutes before going in to the cave and two hours after the volunteers come out from the cave

  2. Change from baseline arterial blood pressure at 2 hours

    Arterial blood pressure was recorded by using a multiparametric monitor

    Measured: 10 minutes before going in to the cave and two hours after the volunteers come out from the cave

  3. Change from baseline pulse oxymetry at 2 hours

    Pulse oxymetry was recorded by using a multiparametric monitor

    Measured: 10 minutes before going in to the cave and two hours after the volunteers come out from the cave

  4. Change from baseline epitympanic temperature at 2 hours

    Epitympanic temperature was measured by using epitympanic probe

    Measured: 10 minutes before going in to the cave and two hours after the volunteers come out from the cave

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Dec 2019
  2. Study start12 Dec 2016
  3. Primary completion12 Nov 2018
  4. Study completion12 Dec 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Other
Enrolment
94 participants (actual)
Target duration
1 Day
IDs, dates and publications
ClinicalTrials.gov ID
NCT04201860
Sponsor's protocol ID
20/2016
Status last verified
Feb 2020
First submitted
12 Dec 2019
Last updated
26 Feb 2020
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Disorder of Blood Gas and Bleeding Disorder, run by Emiliano Petrucci at 1 site in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 26 Feb 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change from baseline arterial blood gases analysis at 2 hours (time frame: 10 minutes before going in to the cave and two hours after the volunteers come out from the cave). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Feb 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in